title: [What is important in therapy of hyperlipoproteinemia. Lipo-Merz retard (etofibrate) lowers the atherogenic index].
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D006801:Humans; D006951:Hyperlipoproteinemias / Q000188:drug therapy*
chemical_list: D000924:Anticholesteremic Agents; D003692:Delayed-Action Preparations; C009746:etofibrate; D002995:Clofibric Acid; D002994:Clofibrate
vernacular_title: Worauf es bei der Therapie der Hyperlipoproteinämie ankommt. Lipo-Merz retard (Etofibrat) senkt den atherogenen Index.